michigan glp-1 nausea class action medications are increasingly common, and it is important your anaesthetist knows if you are taking them. These medications can affect how the stomach empties, which may change how we plan anaesthesia Frontiers | Psychiatric adverse events

Abbreviations CVE: Cardiovascular event EHR: Electronic health record GLP-1RA: Glucagon-like peptide-1 receptor agonist MACE: Major adverse cardiovascular events NAFLD: Non-alcoholic fatty liver disease NASH: Non-alcoholic steatohepatitis PCI: Percutaneous coronary intervention PSM: Propensity score matching SGLT2: Sodiumglucose cotransporter 2 SMD: Standardised mean difference TG: Triacylglycerol References Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes

Among current and previous GLP-1 users, 60.84% said they were concerned about injecting themselves before starting treatment, including 20.89% who said they were very concerned

All patients initiated injectable semaglutide or tirzepatide for obesity or type 2 diabetes and stopped the medication within three to 12 months

Situations like this are becoming increasingly common as GLP-1 medications move across multiple corners Read More Are GLP-1 Drugs Being Prescribed Too Early

Comparing All Three Classes: Which Is Right for You

Early demand for oral GLP-1s is likely to come from people already familiar with weight loss treatments, before awareness spreads more widely into the general public